Gliadin (Deamidated) Antibody, IgG
Gliadin antibodies are produced in response to gluten, which is found in wheat and other similar proteins present in barley, oats and rye. Testing is done to help diagnose celiac disease.
Celiac disease, also known as gluten-sensitive enteropathy, is an autoimmune disease that is triggered in genetically susceptible individuals when they consume gluten containing products. When gluten is present the body produces antibodies that attack the villi in the intestine leading to atrophy of the small intestinal villi or flat mucosa. The disease is associated with HLA variation (DQ2, DQA1*0501, and DQB1*0201) in 95% of patients.
Gold standard diagnosis of celiac disease is still biopsy of the small intestine (demonstrating flat/atrophied mucosa) supported by serological markers. Antibodies against gliadin and tissue transglutaminase (tTG) are of major supportive markers for diagnosis of celiac disease. Therefore, testing for circulating IgG and IgA antibodies to gliadin is usually ordered together with tTG and endomysium antibodies as a panel for diagnosis of celiac disease.
Once a diagnosis has been made, then further testing is done to monitor treatment. The determination of IgG antibodies to gliadin (and/or tTG) is especially important, as approximately 2–5% of celiac patients display an IgA deficiency, thus being missed by IgA subclass tests.
Antibodies to gliadin may be the only serological marker in neonates, as anti-tTG and anti-endomysium antibodies are not present at this age. In addition, anti-gliadin antibodies are the earliest serological marker for pediatricians when diagnosing celiac disease.
- Aid in diagnosis of celiac disease
- Aid in diagnosis of a malabsorptive small intestinal disease characterized by diarrhea
- As an aid in diagnosis of steatorrhea, intestinal cramping, and weight loss
- As an aid in diagnosis of dermatitis herpetiformis
- Monitor treatment of celiac disease
Increased in:
- Celiac disease
- Malabsorptive small intestinal disease
- Steatorrhea
- Intestinal cramping and weight loss
- Dermatitis herpetiformis
| < 3 yr of age | > 3 yr of age |
| < 20 U = Negative | < 25 U = Negative |
| 20–25 U = Equivocal | 25–50 U = Equivocal |
| > 25 U = Positive | > 50 U = Positive |
Serum (SST).
Stability
- Ambient: 1-3 days
- Refrigerated: 7-14 days
- Frozen: 30 days
- Can J Gastroenterol. 2011 Apr;25(4):193-7. Review. [PMID: 21523259]
- J Pediatr Gastroenterol Nutr. 1991 Feb;12(2):150-8. [PMID: 2051264]
- Lancet. 2003 Apr 12;361(9365):1290-2. [PMID: 12699968]
- Stevens,Christine Dorresteyn. Clinical Immunology & Serology: A Laboratory Perspective 3rd edition. Philadelphia: F.A. Davis Company. 2010.